Tuberculosis risk in patients treated with non-anti-tumor necrosis factor-α (TNF-α) targeted biologics and recently licensed TNF-α inhibitors: data from clinical trials and national registries - Cantini, F; Niccoli, L; Goletti, D (J Rheumatol Suppl, 2014)